The latest study on Oncolytic Virus Immunotherapy Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Oncolytic Virus Immunotherapy Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Oncolytic Virus Immunotherapy and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Merck
Amgen
TILT Biotherapeutics
Oncorus
Sorrento Therapeutics
Shanghai Sunway Biotech
Oncolytic Virus Immunotherapy Market Analysis By Type Segment:
Engineering Oncolytic Viruses
Wild-Type Oncolytic Viruses
Oncolytic Virus Immunotherapy Market Analysis By Application Segment:
Hospitals
Clinics
Ambulatory Surgical Centers
Oncolytic Virus Immunotherapy Market Analysis By Regions (Countries):
The Oncolytic Virus Immunotherapy Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Oncolytic Virus Immunotherapy Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Oncolytic Virus Immunotherapy Market:
Oncolytic Virus Immunotherapy market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Oncolytic Virus Immunotherapy Market status and future forecast.
To present the key Oncolytic Virus Immunotherapy Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Oncolytic Virus Immunotherapy Market Size Growth Rate by Type (2016-2027)
1.4.2 Engineering Oncolytic Viruses
1.4.3 Wild-Type Oncolytic Viruses
1.5 Market by Application
1.5.1 Global Oncolytic Virus Immunotherapy Market Share by Application (2016-2027)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Oncolytic Virus Immunotherapy Market Size
2.2 Oncolytic Virus Immunotherapy Growth Trends by Regions
2.2.1 Oncolytic Virus Immunotherapy Market Size by Regions (2016-2027)
2.2.2 Oncolytic Virus Immunotherapy Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Oncolytic Virus Immunotherapy Market Size by Manufacturers
3.1.1 Global Oncolytic Virus Immunotherapy Revenue by Manufacturers (2020)
3.1.2 Global Oncolytic Virus Immunotherapy Revenue Market Share by Manufacturers (2020)
3.1.3 Global Oncolytic Virus Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.2 Oncolytic Virus Immunotherapy Key Players Head office and Area Served
3.3 Key Players Oncolytic Virus Immunotherapy Product/Solution/Service
3.4 Date of Enter into Oncolytic Virus Immunotherapy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Oncolytic Virus Immunotherapy Market Size by Type (2016-2020)
4.2 Global Oncolytic Virus Immunotherapy Market Size by Application (2016-2020)
5 United States
5.1 United States Oncolytic Virus Immunotherapy Market Size (2016-2020)
5.2 Oncolytic Virus Immunotherapy Key Players in United States
5.3 United States Oncolytic Virus Immunotherapy Market Size by Type
5.4 United States Oncolytic Virus Immunotherapy Market Size by Application
6 Europe
6.1 Europe Oncolytic Virus Immunotherapy Market Size (2016-2020)
6.2 Oncolytic Virus Immunotherapy Key Players in Europe
6.3 Europe Oncolytic Virus Immunotherapy Market Size by Type
6.4 Europe Oncolytic Virus Immunotherapy Market Size by Application
7 China
7.1 China Oncolytic Virus Immunotherapy Market Size (2016-2020)
7.2 Oncolytic Virus Immunotherapy Key Players in China
7.3 China Oncolytic Virus Immunotherapy Market Size by Type
7.4 China Oncolytic Virus Immunotherapy Market Size by Application
8 Japan
8.1 Japan Oncolytic Virus Immunotherapy Market Size (2016-2020)
8.2 Oncolytic Virus Immunotherapy Key Players in Japan
8.3 Japan Oncolytic Virus Immunotherapy Market Size by Type
8.4 Japan Oncolytic Virus Immunotherapy Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Oncolytic Virus Immunotherapy Market Size (2016-2020)
9.2 Oncolytic Virus Immunotherapy Key Players in Southeast Asia
9.3 Southeast Asia Oncolytic Virus Immunotherapy Market Size by Type
9.4 Southeast Asia Oncolytic Virus Immunotherapy Market Size by Application
10 India
10.1 India Oncolytic Virus Immunotherapy Market Size (2016-2020)
10.2 Oncolytic Virus Immunotherapy Key Players in India
10.3 India Oncolytic Virus Immunotherapy Market Size by Type
10.4 India Oncolytic Virus Immunotherapy Market Size by Application
11 Central & South America
11.1 Central & South America Oncolytic Virus Immunotherapy Market Size (2016-2020)
11.2 Oncolytic Virus Immunotherapy Key Players in Central & South America
11.3 Central & South America Oncolytic Virus Immunotherapy Market Size by Type
11.4 Central & South America Oncolytic Virus Immunotherapy Market Size by Application
12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 Oncolytic Virus Immunotherapy Introduction
12.1.4 Merck Revenue in Oncolytic Virus Immunotherapy Business (2020)
12.1.5 Merck Recent Development
12.2 Amgen
12.2.1 Amgen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Oncolytic Virus Immunotherapy Introduction
12.2.4 Amgen Revenue in Oncolytic Virus Immunotherapy Business (2020)
12.2.5 Amgen Recent Development
12.3 TILT Biotherapeutics
12.3.1 TILT Biotherapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Oncolytic Virus Immunotherapy Introduction
12.3.4 TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2020)
12.3.5 TILT Biotherapeutics Recent Development
12.4 Oncorus
12.4.1 Oncorus Company Details
12.4.2 Company Description and Business Overview
12.4.3 Oncolytic Virus Immunotherapy Introduction
12.4.4 Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2020)
12.4.5 Oncorus Recent Development
12.5 Sorrento Therapeutics
12.5.1 Sorrento Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Oncolytic Virus Immunotherapy Introduction
12.5.4 Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2020)
12.5.5 Sorrento Therapeutics Recent Development
12.6 Shanghai Sunway Biotech
12.6.1 Shanghai Sunway Biotech Company Details
12.6.2 Company Description and Business Overview
12.6.3 Oncolytic Virus Immunotherapy Introduction
12.6.4 Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2020)
12.6.5 Shanghai Sunway Biotech Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Oncolytic Virus Immunotherapy Key Market Segments
Table Key Players Oncolytic Virus Immunotherapy Covered
Table Global Oncolytic Virus Immunotherapy Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Oncolytic Virus Immunotherapy Market Size Market Share by Type 2016-2027
Figure Engineering Oncolytic Viruses Figures
Table Key Players of Engineering Oncolytic Viruses
Figure Wild-Type Oncolytic Viruses Figures
Table Key Players of Wild-Type Oncolytic Viruses
Table Global Oncolytic Virus Immunotherapy Market Size Growth by Application 2016-2027 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Oncolytic Virus Immunotherapy Report Years Considered
Table Global Oncolytic Virus Immunotherapy Market Size 2016-2027 (Million US$)
Figure Global Oncolytic Virus Immunotherapy Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Oncolytic Virus Immunotherapy Market Size by Regions 2016-2027 (Million US$)
Table Global Oncolytic Virus Immunotherapy Market Size by Regions 2016-2020 (Million US$)
Table Global Oncolytic Virus Immunotherapy Market Share by Regions 2016-2020
Figure Global Oncolytic Virus Immunotherapy Market Share by Regions 2016-2020
Figure Global Oncolytic Virus Immunotherapy Market Share by Regions 2020
Table Market Top Trends
Table Global Oncolytic Virus Immunotherapy Revenue by Manufacturers (2020) (Million US$)
Table Global Oncolytic Virus Immunotherapy Market Share by Manufacturers (2020)
Figure Global Oncolytic Virus Immunotherapy Market Share by Manufacturers in 2020
Table Global Oncolytic Virus Immunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Oncolytic Virus Immunotherapy Product/Solution/Service
Table Date of Enter into Oncolytic Virus Immunotherapy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Oncolytic Virus Immunotherapy Market Size by Type (2016-2020) (Million US$)
Table Global Oncolytic Virus Immunotherapy Market Size Share by Type (2016-2020)
Figure Global Oncolytic Virus Immunotherapy Market Size Market Share by Type (2016-2020)
Table Global Oncolytic Virus Immunotherapy Market Size by Application (2016-2020) (Million US$)
Table Global Oncolytic Virus Immunotherapy Market Size Share by Application (2016-2020)
Figure Global Oncolytic Virus Immunotherapy Market Size Market Share by Application (2016-2020)
Figure Global Oncolytic Virus Immunotherapy Revenue Market Share by Application in 2020
Figure United States Oncolytic Virus Immunotherapy Market Size 2016-2020 (Million US$)
Table United States Key Players Oncolytic Virus Immunotherapy Revenue (2020) (Million US$)
Table United States Key Players Oncolytic Virus Immunotherapy Market Share (2020)
Table United States Oncolytic Virus Immunotherapy Market Size by Type (2016-2020) (Million US$)
Table United States Oncolytic Virus Immunotherapy Market Share by Type (2016-2020)
Table United States Oncolytic Virus Immunotherapy Market Size by Application (2016-2020) (Million US$)
Table United States Oncolytic Virus Immunotherapy Market Share by Application (2016-2020)
Figure Europe Oncolytic Virus Immunotherapy Market Size 2016-2020 (Million US$)
Table Europe Key Players Oncolytic Virus Immunotherapy Revenue (2020) (Million US$)
Table Europe Key Players Oncolytic Virus Immunotherapy Market Share (2020)
Table Europe Oncolytic Virus Immunotherapy Market Size by Type (2016-2020) (Million US$)
Table Europe Oncolytic Virus Immunotherapy Market Share by Type (2016-2020)
Table Europe Oncolytic Virus Immunotherapy Market Size by Application (2016-2020) (Million US$)
Table Europe Oncolytic Virus Immunotherapy Market Share by Application (2016-2020)
Figure China Oncolytic Virus Immunotherapy Market Size 2016-2020 (Million US$)
Table China Key Players Oncolytic Virus Immunotherapy Revenue (2020) (Million US$)
Table China Key Players Oncolytic Virus Immunotherapy Market Share (2020)
Table China Oncolytic Virus Immunotherapy Market Size by Type (2016-2020) (Million US$)
Table China Oncolytic Virus Immunotherapy Market Share by Type (2016-2020)
Table China Oncolytic Virus Immunotherapy Market Size by Application (2016-2020) (Million US$)
Table China Oncolytic Virus Immunotherapy Market Share by Application (2016-2020)
Figure Japan Oncolytic Virus Immunotherapy Market Size 2016-2020 (Million US$)
Table Japan Key Players Oncolytic Virus Immunotherapy Revenue (2020) (Million US$)
Table Japan Key Players Oncolytic Virus Immunotherapy Market Share (2020)
Table Japan Oncolytic Virus Immunotherapy Market Size by Type (2016-2020) (Million US$)
Table Japan Oncolytic Virus Immunotherapy Market Share by Type (2016-2020)
Table Japan Oncolytic Virus Immunotherapy Market Size by Application (2016-2020) (Million US$)
Table Japan Oncolytic Virus Immunotherapy Market Share by Application (2016-2020)
Figure Southeast Asia Oncolytic Virus Immunotherapy Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Oncolytic Virus Immunotherapy Revenue (2020) (Million US$)
Table Southeast Asia Key Players Oncolytic Virus Immunotherapy Market Share (2020)
Table Southeast Asia Oncolytic Virus Immunotherapy Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Oncolytic Virus Immunotherapy Market Share by Type (2016-2020)
Table Southeast Asia Oncolytic Virus Immunotherapy Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Oncolytic Virus Immunotherapy Market Share by Application (2016-2020)
Figure India Oncolytic Virus Immunotherapy Market Size 2016-2020 (Million US$)
Table India Key Players Oncolytic Virus Immunotherapy Revenue (2020) (Million US$)
Table India Key Players Oncolytic Virus Immunotherapy Market Share (2020)
Table India Oncolytic Virus Immunotherapy Market Size by Type (2016-2020) (Million US$)
Table India Oncolytic Virus Immunotherapy Market Share by Type (2016-2020)
Table India Oncolytic Virus Immunotherapy Market Size by Application (2016-2020) (Million US$)
Table India Oncolytic Virus Immunotherapy Market Share by Application (2016-2020)
Figure Central & South America Oncolytic Virus Immunotherapy Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Oncolytic Virus Immunotherapy Revenue (2020) (Million US$)
Table Central & South America Key Players Oncolytic Virus Immunotherapy Market Share (2020)
Table Central & South America Oncolytic Virus Immunotherapy Market Size by Type (2016-2020) (Million US$)
Table Central & South America Oncolytic Virus Immunotherapy Market Share by Type (2016-2020)
Table Central & South America Oncolytic Virus Immunotherapy Market Size by Application (2016-2020) (Million US$)
Table Central & South America Oncolytic Virus Immunotherapy Market Share by Application (2016-2020)
Table Merck Company Details
Table Merck Revenue in Oncolytic Virus Immunotherapy Business (2020) (Million US$)
Figure Merck Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2020)
Table Merck Recent Development
Table Amgen Company Details
Table Amgen Revenue in Oncolytic Virus Immunotherapy Business (2020)(Million US$)
Figure Amgen Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2020)
Table Amgen Recent Development
Table TILT Biotherapeutics Company Details
Table TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2020)(Million US$)
Figure TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2020)
Table TILT Biotherapeutics Recent Development
Table Oncorus Company Details
Table Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2020)(Million US$)
Figure Oncorus Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2020)
Table Oncorus Recent Development
Table Sorrento Therapeutics Company Details
Table Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2020)(Million US$)
Figure Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2020)
Table Sorrento Therapeutics Recent Development
Table Shanghai Sunway Biotech Company Details
Table Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2020)(Million US$)
Figure Shanghai Sunway Biotech Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2020)
Table Shanghai Sunway Biotech Recent Development
Table Global Oncolytic Virus Immunotherapy Market Size by Regions (Million US$) 2021-2027
Figure Global Oncolytic Virus Immunotherapy Market Size Share by Regions (2021-2027)
Figure Global Oncolytic Virus Immunotherapy Market Size Share by Regions in 2027
Figure United States Oncolytic Virus Immunotherapy Market Size Forecast (2021-2027)(Million USD)
Figure Europe Oncolytic Virus Immunotherapy Market Size Forecast (2021-2027)(Million USD)
Figure China Oncolytic Virus Immunotherapy Market Size Forecast (2021-2027)(Million USD)
Figure Japan Oncolytic Virus Immunotherapy Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Oncolytic Virus Immunotherapy Market Size Forecast (2021-2027)(Million USD)
Figure India Oncolytic Virus Immunotherapy Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Oncolytic Virus Immunotherapy Market Size Forecast (2021-2027)(Million USD)
Table Global Oncolytic Virus Immunotherapy Market Size by Product (2021-2027) (Million US$)
Figure Global Oncolytic Virus Immunotherapy Market Size by Product (2021-2027)
Figure Global Oncolytic Virus Immunotherapy Market Size by Product in 2027
Table Global Oncolytic Virus Immunotherapy Market Size by Application (2021-2027) (Million US$)
Figure Global Oncolytic Virus Immunotherapy Market Size by Application (2021-2027)
Figure Global Oncolytic Virus Immunotherapy Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources